Drugs / Levact
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02467946 | Jan 2016 → Apr 2022 | — | Centre Antoine Lacassagne | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Levact | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02467946 ↗ |